Collegium Pharmaceutical, Inc. - Common Stock (NQ:COLL)

The stocks in this article have caught Wall Street’s attention in a big way, with price targets implying returns above 20%. But investors should take these f...

1 of Wall Street’s favorite stocks with promising prospects and 2 we turn down

October 30, 2026

Collegium Pharmaceutical and Boston Legacy FC Expand Their Partnership Beyond Matchday to Communities Across Massachusetts

Performance

52-Week Range 53.2% below 52-week high

23.78

21.4352W Low 50.7952W High

1 Week 2.9% below 1-week high

22.661W Low 24.501W High

Collegium Pharmaceutical, Inc. - Common Stock (COLL) traded between $21.43 and $50.79 over the past 52 weeks and last traded at $23.78, 53.2% below its 52-week high. Over the past week it ranged between $22.66 and $24.50.

Past 12 Months

+2.4%

+8.7%

-33.4%

-32.7%

-47.8%

-34.1%

1W +$0.55

1M +$1.91

3M -$11.95

6M -$11.54

YTD -$21.75

1Y -$12.32

COLL was -34.1% over the past year, -32.7% over six months, -47.8% year to date, +2.4% in the last week.

12 Months vs Market

COLL

-34.1%

DIA

+12.1%

SPY

+12.0%

QQQ

+10.3%

IWM

+15.1%

Over the past 12 months COLL returned -34.1% versus DIA (Dow) +12.1%, SPY (S&P 500) +12.0%, QQQ (Nasdaq 100) +10.3% and IWM (Russell 2000) +15.1%.

Volume & Liquidity 0.18× 3-mo avg

Today 147,813 3-mo avg 819.9K

518.0K

633.9K

819.9K

627.0K

YTD

578.1K

576.4K

COLL most recently traded 147,813 shares against a 3-month average daily volume of 819.9K.

More News

October 29, 2026

Q2 earnings highs and lows: Collegium Pharmaceutical (NASDAQ:COLL) vs the rest of the branded pharmaceuticals stocks

October 25, 2026

Collegium Pharmaceutical (NASDAQ:COLL) Tumbles on Revenue Miss and Lowered Guidance ↗

August 06, 2026

Via Chartmill

Collegium to Report Third Quarter 2026 Financial Results on November 5, 2026

October 22, 2026

Collegium to Present Pediatric and Real-World Research Across ADHD Portfolio at AACAP and NEI Fall Congresses

October 21, 2026

Collegium Launches "Start Talking ADHD" with Practical Support to Help Families Navigate Care, School and Everyday Life

October 06, 2026

3 Healthcare Stocks That Concern Us

September 30, 2026

3 Value Stocks That Fall Short

September 28, 2026

1 Oversold Stock Ready to Bounce Back and 2 We Find Risky

September 22, 2026

1 Cash-Producing Stock on Our Buy List and 2 That Underwhelm

September 21, 2026

Collegium to Participate in Upcoming Investor Conferences

September 08, 2026

Collegium Pharmaceutical (COLL) Q2 2026 Earnings Call Transcript ↗

August 13, 2026

Via The Motley Fool

Collegium Announces $50 Million Accelerated Share Repurchase Program

August 13, 2026

5 Revealing Analyst Questions From Collegium Pharmaceutical’s Q2 Earnings Call

August 13, 2026

COLL Q2 Deep Dive: ADHD Expansion and Pain Business Headwinds Shape Guidance

August 07, 2026

Collegium Pharmaceutical (NASDAQ:COLL) Reports Sales Below Analyst Estimates In Q2 CY2026 Earnings, Stock Drops

Collegium Pharmaceutical Q2 Earnings Call Highlights ↗

August 06, 2026

Via MarketBeat

August 06, 2026

Collegium Reports Second Quarter 2026 Financial Results and Highlights Recent Company Progress

August 06, 2026

Collegium Pharmaceutical (COLL) Reports Earnings Tomorrow: What To Expect

August 04, 2026

Winners And Losers Of Q1: Collegium Pharmaceutical (NASDAQ:COLL) Vs The Rest Of The Branded Pharmaceuticals Stocks

July 23, 2026

Collegium to Report Second Quarter 2026 Financial Results on August 6, 2026

July 23, 2026

Collegium Pharmaceutical Announces New Corporate Headquarters at One Lincoln in Boston

July 20, 2026

1 Healthcare Stock with Competitive Advantages and 2 We Question

July 16, 2026